Christopher Flint OBrien, Chief Medical Officer at NEUROCRINE BIOSCIENCES INC (NBIX), sold 105,634 shares at $53.32 ($5.6M) on 2017-05-18, disclosed to the SEC on 2017-05-23.
Open-market sale of $5.6M NBIX by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| NBIX | SELL | 2017-11-06 | $7.4M | — | Filing → |
| NBIX | SELL | 2017-10-03 | $423K | — | Filing → |
| NBIX | SELL | 2017-09-07 | $6.1M | — | Filing → |